ACE–ACE2 Gene–Gene Interaction in Knee Osteoarthritis Severity: Evidence for Context-Dependent Genetic Effects
Keywords:
ACE polymorphism, ACE2 polymorphism, gene–gene interaction, knee osteoarthritis, Osteoarthritis SeverityAbstract
Background and aim:
Osteoarthritis (OA) is a multifactorial disease involving biomechanical, inflammatory, and metabolic pathways. The renin–angiotensin system (RAS) has been implicated in OA pathogenesis, yet most studies assess genetic variants independently. The combined effect of angiotensin-converting enzyme (ACE) and ACE2 polymorphisms, and their interaction with metabolic factors, remains unclear. This study aimed to evaluate the independent and combined contributions of ACE I/D and ACE2 G8790A polymorphisms to knee OA severity.
Methods:
This cross-sectional study included 80 women aged ≥40 years with primary knee OA, classified as mild (n=40) or severe (n=40) using Kellgren–Lawrence grading. ACE I/D and ACE2 G8790A polymorphisms were analyzed individually and as a combined genetic model, categorized into low-risk and intermediate–high risk groups. Associations were assessed using chi-square or Fisher’s exact test, with odds ratios (ORs) and 95% confidence intervals (CIs). Subgroup analysis was performed based on obesity.
Results:
A significant association emerged in the combined model, with increased odds of severe OA in the intermediate–high risk group (OR 3.78; 95% CI 1.33–10.7; P=0.02). The effect was stronger in obese individuals (OR 5.91; 95% CI 1.05–32.8; P=0.03) but not significant in non-obese participants (OR 2.42; 95% CI 0.57–10.3; P=0.25).
Conclusions: The association between RAS-related polymorphisms and knee OA severity becomes evident at the level of gene–gene interaction and is amplified under metabolically unfavorable conditions. These findings support a context-dependent model of genetic risk, in which ACE–ACE2 imbalance contributes to inflammatory and degenerative processes in osteoarthritis.
References
1. Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745-59. doi: 10.1016/S0140-6736(19)30417-9.
2. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-22.
3. Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26(3):355-69. doi: 10.1016/j.cger.2010.03.001.
4. Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;64(6):1697-707. doi: 10.1016/j.cger.2010.03.001.
5. Berenbaum F. Osteoarthritis as an inflammatory disease. Osteoarthr Cartil. 2013;21(1):16-21. doi: 10.1016/j.joca.2012.11.012.
6. Zhai G, Huang J. Genetics of osteoarthritis. Best Pract Res Clin Rheumatol. 2024;38(4):101972. doi: 10.1016/j.berh.2024.101972.
7. Wu Y, Lu X, Li M, et al. Renin-angiotensin system in osteoarthritis: a new potential therapy. Int Immunopharmacol. 2019;75:105796. doi: 10.1016/j.intimp.2019.105796.
8. Mustari MN, Massi MN, Usman MA, et al. Association between angiotensin-converting enzyme (ACE) gene I/D polymorphism with the risk of knee OA: a systematic review, meta-analysis, and meta-regression. F1000Res. 2024;13:146. doi: 10.12688/f1000research.140233.1.
9. Pan Y. Angiotensin-converting enzyme 2 G8790A polymorphisms are associated with COVID-19 severity. J Infect Dev Ctries. 2023;17(6):819-25. doi: 10.3855/jidc.17762.
10. Ningtyas MC, Ansharullah BA, Sutanto H, Prajitno JH. Beyond weight: exploring the nexus between obesity and osteoarthritis. Med Fam Semer. 2025;51(6):102526. doi: 10.1016/j.semerg.2025.102526.
11. Santos RAS, Oudit GY, Verano-Braga T, Canta G, Steckelings UM, Bader M. The renin-angiotensin system: going beyond the classical paradigms. Am J Physiol Heart Circ Physiol. 2019;316(5):H958-70. doi: 10.1152/ajpheart.00723.2018.
12. Bilgin E, Haznedaroglu IC. The joint-local renin-angiotensin system in rheumatoid arthritis and osteoarthritis: mechanistic evidence, disease-specific patterns, and translational perspectives. Rheumatol Int. 2026;46(2):43. doi: 10.1007/s00296-026-06073-9.
13. Frigolet ME, Torres N, Tovar AR. The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity. J Nutr Biochem. 2013;24(12):2003-15. doi: 10.1016/j.jnutbio.2013.07.002.
14. Nedunchezhiyan U, Varughese I, Sun AR, Wu X, Crawford R, Prasadam I. Obesity, inflammation, and immune system in osteoarthritis. Front Immunol. 2022;13:907750. doi: 10.3389/fimmu.2022.907750.
15. Liu-Galvin R, Orlando FA, Saguil AA, et al. More evidence of the health risks of normal weight obesity: the association with systemic inflammation. Front Med. 2025;18(12):1-9.
16. Sabir JSM, Omri AE, Khan IA, et al. ACE insertion/deletion genetic polymorphism, serum ACE levels and high dietary salt intake influence the risk of obesity development among the Saudi adult population. J Renin Angiotensin Aldosterone Syst. 2019;20(3):1470320319870945. doi: 10.1177/1470320319870945.
17. Lin C, Chen HC, Fang WH, et al. Angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to osteoarthritis of the knee: a case-control study and meta-analysis. PLoS One. 2016;11(9):e0161754. doi: 10.1371/journal.pone.0161754.
18. Ai J, Liu J, Liu Y, Li D, Hao X, Pei B. Association between angiotensin-converting enzyme gene insertion/deletion polymorphism and osteoarthritis: a meta-analysis. Int J Clin Exp Med. 2016;9(10):19130-41.
19. Chen G, Hu S, Lai Z, Qiu B. Association between ACE gene I/D polymorphism and knee osteoarthritis in a Chinese population. Biosci Rep. 2019;39(2):BSR20181713. doi: 10.1042/BSR20181713.
20. Hong SJ, Yang HI, Yoo MC, In CS, Yim SV, Jin SY, et al. Angiotensin converting enzyme gene polymorphism in Korean patients with primary knee osteoarthritis. Exp Mol Med. 2003;35(3):189-95. doi: 10.1038/emm.2003.26.
How to Cite
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

